- Parataxis invests $18.5M to transform Bridge Bio into South Korea’s first BTC treasury agency.
- Bridge Biotherapeutics inventory surged over 20% after Parataxis introduced its acquisition plans.
- Over 237 public companies now maintain Bitcoin, with institutional adoption rising sharply worldwide.
Parataxis Holdings LLC has signed a definitive settlement to amass a controlling stake in South Korean biotech agency Bridge Biotherapeutics, Inc. (KOSDAQ: 288330) for KRW 25 billion, roughly $18.5 million.
This introduced transfer will create the primary institutionally backed Bitcoin-native treasury firm on South Korea’s KOSDAQ alternate. Pending shareholder approval and normal closing circumstances, Bridge Biotherapeutics will rebrand as Parataxis Korea and keep a list within the inventory market, making a brand new shift as a clinical-stage biotech developer.
Edward Chin, Founder and CEO of Parataxis Holdings and Co-Founder of Parataxis Capital Management, will be part of the Board of Directors. At the identical time, Parataxis Capital Partner Andrew Kim is about to take over as CEO.
Bridge Bio’s co-founder, James Jungkue Lee, will proceed main the biotech phase. “We see South Korea as an vital market within the evolution of BTC adoption. Our intent is to assist institutional entry to BTC publicity whereas emphasizing sound company governance and disciplined capital administration,” Kim said.
Parataxis Spurs Bitcoin Adoption Amid Korean Market Shift
The deal will place Parataxis Korea as a hybrid firm that maintains its biotech analysis whereas constructing a Bitcoin treasury, drawing inspiration from different world gamers like Strategy within the US and Metaplanet in Japan.
This technique follows South Korea’s monetary regulators’ opening of recent channels for institutional funding in crypto. In 2025, the Financial Services Commission initiated a pilot program wherein greater than 3,500 companies {and professional} buyers can have the chance to open “real-name” accounts paving the way in which to the provision of digital property.
Similarly, public firms are growing Bitcoin holdings on their steadiness sheets. As per BitcoinTreasuries.NET, over 237 publicly traded firms now have Bitcoin of their possession, which makes up roughly 3.96% of all the provide of BTC. Standard Chartered notes a pointy improve in conventional firms adopting Bitcoin treasury methods, which has doubled since April.
Parataxis Holdings’ management believes that establishing a BTC treasury on an institutional platform is not going to solely profit shareholders however may strengthen Korea’s monetary sector. “We are extremely excited to create the primary BTC treasury firm in South Korea backed by an institutional-grade platform,” mentioned Chin.
Market Reaction and Outlook for Bitcoin Treasury Firms
The announcement prompted Bridge Biotherapeutics to surge over 20%, reflecting market anticipation of the brand new technique. Nevertheless, the shares are nonetheless down sharply year-to-date and since their all-time highs.
Additionally, the acquisition follows the rise in reputation of Bitcoin-native treasury methods amongst US and Japanese-listed companies. While such strikes draw consideration for his or her potential upside, analysts like Charles Schwab have cautioned that heavy publicity to Bitcoin can introduce dangers if the asset worth drops sharply.
Parataxis Holdings will present extra info following its shareholder assembly in August, with Shin & Kim LLC and Deloitte appearing as authorized and monetary advisers. The firm can be closing one other fund with an analogous technique and making ready to launch extra funding automobiles, demonstrating its dedication to institutional Bitcoin adoption in Asia.
Related Reading | Here’s Why Bitcoin Price Is Eying a Bullish Rally After the Fed Meeting
